GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB) » Definitions » EBITDA Margin %

Nuvation Bio (Nuvation Bio) EBITDA Margin % : 0.00% (As of Sep. 2021)


View and export this data going back to 2020. Start your Free Trial

What is Nuvation Bio EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Nuvation Bio's EBITDA for the three months ended in Sep. 2021 was $-22.72 Mil. Nuvation Bio's Revenue for the three months ended in Sep. 2021 was $0.00 Mil. Therefore, Nuvation Bio's EBITDA margin for the quarter that ended in Sep. 2021 was 0.00%.


Nuvation Bio EBITDA Margin % Historical Data

The historical data trend for Nuvation Bio's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio EBITDA Margin % Chart

Nuvation Bio Annual Data
Trend Dec20 Dec21
EBITDA Margin %
- -

Nuvation Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
EBITDA Margin % Get a 7-Day Free Trial - - - - -

Competitive Comparison of Nuvation Bio's EBITDA Margin %

For the Biotechnology subindustry, Nuvation Bio's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nuvation Bio's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nuvation Bio's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Nuvation Bio's EBITDA Margin % falls into.



Nuvation Bio EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Nuvation Bio's EBITDA Margin % for the fiscal year that ended in Dec. 2020 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2020 )/Revenue (A: Dec. 2020 )
=0/0
= %

Nuvation Bio's EBITDA Margin % for the quarter that ended in Sep. 2021 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2021 )/Revenue (Q: Sep. 2021 )
=-22.721/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuvation Bio  (NYSE:NUVB) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Nuvation Bio EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuvation Bio (Nuvation Bio) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
1500 Broadway, Suite 1401, New York, NY, USA, 10036
Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.